Navigation Links
IRIDEX Reports Record 2012 Fourth Quarter Results
Date:2/28/2013

e traditional single spot mode.  Management believes that the clinical and practice benefits of this technology will accelerate the adoption of IRIDEX' proprietary MicroPulse™ technology as it applies to several clinical procedures.

Conference Call IRIDEX management will conduct a conference call later today, Thursday, February 28, 2013 at 5:00 p.m. Eastern Time.  Interested parties may access the live conference call via telephone by dialing (866) 225-8754 (U.S.) or (480) 629-9818 (International) and quoting Conference ID 4603021, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, February 28, 2013 through Thursday, March 7, 2013 by dialing (800) 406-7325 (U.S.) or (303) 590-3030 (International) and entering Access Code 4603021. In addition, later today an archived version of the webcast will be available on the Company's website at www.iridex.com.

About IRIDEX IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the Company's website at http://www.iridex.com/.

Safe Harbor StatementThis announcement contains forward-looking statements within the meaning of Section 27A of the Securiti
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. IRIDEX Announces Fourth Quarter and Full Year 2012
2. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
3. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
4. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
5. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
6. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
7. IRIDEX Reports 2012 Third Quarter Results
8. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
9. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
10. IRIDEX Reports 2012 Second Quarter Results
11. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... CVS Caremark Corporation (NYSE: CVS ) announced today ... in connection with its previously announced cash tender offers (the ... and all of its 6.250% Senior Notes due 2027 (the ... amount of its 6.125% Senior Notes due 2039, 5.750% Senior ... the "Maximum Tender Offer Notes" and together with the Any ...
(Date:8/21/2014)... /CNW/ - Bedrocan Cannabis Corp., previously Bedrocan Canada Inc. ... Board of Directors, enhancing executive oversight and strengthening ... leading licensed producer of medicinal cannabis in ... years, experience in producing and supplying government-regulated pharmaceutical-grade ... As previously announced in a ...
(Date:8/21/2014)... , Aug. 21, 2014  SI-BONE, Inc. ( ... that pioneered the use of the iFuse Implant System, ... for fusion of the sacroiliac (SI) joint, announced that ... update to its Lumbar Fusion Medical Policy No. 91590-R4 ... procedure.  The policy states that the fusion procedure, which ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... QPT: TSX Venture Exchange, EDMONTON, May 02, 2007 ... Quest is pleased to provide an,update on the ... cancer. , Prostate cancer is the second leading ... 230,000 new cases and 30,000 deaths,per year. Current ...
... 2007 - Acorda Therapeutics, Inc.(R),(Nasdaq: ACOR) today ... trial,of Fampridine-SR in people with multiple sclerosis ... Andrew Goodman, M.D.,Director of the Multiple Sclerosis ... results on walking ability, leg,strength, spasticity and ...
Cached Medicine Technology:Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7
(Date:8/21/2014)... worlds of personal care and yoga are coming together ... products. BaliniSports will be shipping free samples ... qualifying purchases for a limited time. “The marriage between ... simply perfect,” said Ada Hung, founder and president of ... intended to give people in the yoga community a ...
(Date:8/21/2014)... Relias Learning, the leader in SaaS-based training ... markets, announced the latest release of its flagship LMS ... API. , “Supporting the Tin Can API ensures ... mobile learning capabilities and the ability to leverage the ... says Jim Triandiflou, CEO of Relias Learning. “To provide ...
(Date:8/21/2014)... peripheral neuropathy is important for the successful treatment ... Affiliated Hospital of Kunming Medical University, China, led ... sensitive index for nerve conduction studies in the ... with diabetes mellitus. Nerve conduction studies revealed that ... velocity was slower, and sensory nerve action potential ...
(Date:8/21/2014)... Bedros Keuilian’s Annual Fitness Business Summit is considered ... many people already earning seven-figure incomes. But his annual ... open to the owners of Keuilian’s own international fitness boot ... Body Boot Camp World Conference will also be attended by ... camp or are struggling with their own boot camp ...
(Date:8/21/2014)... Beach, FL (PRWEB) August 21, 2014 ... FZ LLC are pleased to announce the healthcare ... loaded onto operational/production servers. , The company anticipates ... as connections are established between individual physicians, via interfaces, ... collection platforms and finally with electronic data exchanges and ...
Breaking Medicine News(10 mins):Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2Health News:Relias Learning Announces Support for Tin Can API 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 4
... November 1, 2008 at this year,s liver ... 4, SAN FRANCISCO, Oct. 29 Two studies presented ... of Liver Diseases,paint a different picture of survival based on ... Researchers at the Baylor College of Medicine used a United ...
... at subclinical level and in early lactation ... would benefit producers, ... and diagnosing mastitis in dairy cows are not serving the,needs of ... at the recent annual meeting of the American,Association of Bovine Practitioners ...
... Medical,Technologies, Inc. (the "Company") (Nasdaq: CMED ... develops, manufactures and markets advanced in-,vitro diagnostic ... attending the,Credit Suisse Asian Healthcare Conference., ... China, China Medical Technologies, management team ...
... Handheld Device is First to Use IPL to ... 29 CLRS Technology today,announced the CLARO acne-clearing ... Drug Administration (FDA) for treatment of mild to ... use Intense Pulsed,Light (IPL) for treatment of acne, ...
... Calif., Oct. 29 What else could you ... Committee famously spent,on wardrobe and makeup for Gov. ... nurse who can be outfitted in scrubs,for just ... would outfit 15,000,RNs in scrubs," notes Geri Jenkins, ...
... Insurance Offers Insurance Guidance to Canadian Consumers , ... ... citizens of Canada face growing challenges due to economic issues ... cutbacks in Canada,s health care system and shrinking contributions by ...
Cached Medicine News:Health News:No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation, but Long-Term Results Not as Good for African-American Adults 2Health News:No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation, but Long-Term Results Not as Good for African-American Adults 3Health News:Dairy Veterinarians Highlight Need for Improved Methods for Detecting Mastitis 2Health News:CLARO Receives FDA-Clearance for Treatment of Acne 2Health News:Nurses Present Palin Clothing Line Website ... and Other Ways the Money Could Have Been Spent 2Health News:Leading Insurer Offers Education on How Supplemental Insurance Can Help Offset Challenging Economic Trends in Canadian Market 2Health News:Leading Insurer Offers Education on How Supplemental Insurance Can Help Offset Challenging Economic Trends in Canadian Market 3Health News:Leading Insurer Offers Education on How Supplemental Insurance Can Help Offset Challenging Economic Trends in Canadian Market 4Health News:Leading Insurer Offers Education on How Supplemental Insurance Can Help Offset Challenging Economic Trends in Canadian Market 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: